FindTrial
Sign In

Influence of Vitamin D supplementation on the Success of Dental Implants placed in Diabetic Subjects

Effect of Vitamin D supplementation on dental implant stability, bone implant contact and bone morphology in diabetic and non-diabetic patients with Vitamin D deficiency and healthy patients in Bangalore- A Controlled Clinical Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087645
Enrollment
30
Registered
2025-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K089- Disorder of teeth and supporting structures, unspecified Health Condition 2: E116- Type 2 diabetes mellitus with other specified complications Health Condition 3: E559- Vitamin D deficiency, unspecified

Interventions

Intervention1: Group 2- 10 samples-Vitamin D deficient group: 1. Patients requiring dental implant for replacement of missing teeth 2. Non-diabetic patients with less than 6% HbA1c levels. 3. Serum vi

Sponsors

Navneeth Acharya G A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in the study, aged 20-70 yrs requiring prosthetic rehabilitation. 2. Patient choice of replacement is implant-supported fixed prosthesis. 3. Patients with Vitamin D deficiency of less than 30ng/mL. 4. Well controlled Diabetic patients with HbA1c levels 6 to 7% or who are on antihyperglycemic drugs.

Exclusion criteria

Exclusion criteria: 1. Surgical Complications including loss of buccal or lingual or palatal cortical plate. 2. Socket preservation procedures 3. Development of oral diseases or any other systemic diseases like osteoporosis. 4. Heavy smokers (more than 10 Cigarettes per day). 5. Patients under the age of 18 yrs. 6. Patients with chronic periodontitis. 7. Chronic treatment with any medication known to affect bone turnover such as heparin, cyclosporine, bisphosphonates, and chemotherapeutic drugs â?? methotrexate. 8. Exit Criteria-Voluntary withdrawal and development of oral or systemic disease.

Design outcomes

Primary

MeasureTime frame
IMPLANT STABILITY-â??Utilizing electronic technology resonance frequency analysis, implant stability will be evaluated. ISQ (implant stability quotient) values will be used to express the measured values.Timepoint: Baseline- at surgery 3 months after implant surgery—

Secondary

MeasureTime frame
RADIOLOGICAL ASSESSMENT-Bone to implant contact ratioTimepoint: Baseline- at surgery 3 months after implant surgery;HISTOLOGICAL ANALYSISTimepoint: Trephine bone is taken at the time of surgery for histological analysis for osteogenesis potential—

Countries

India

Contacts

Public ContactNavneeth Acharya G A

Faculty of Dental Sciences, Ramaiah University of Applied sciences

vibshetty6@gmail.com9845305455

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026